A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model
J Clin Hypertens (Greenwich). 2012;14:877–886. ©2012 Wiley Periodicals, Inc. Multiple barriers can influence adherence to antihypertensive medications. The aim of this systematic review was to determine what adherence barriers were included in each instrument and to describe the psychometric propert...
Gespeichert in:
Veröffentlicht in: | The journal of clinical hypertension (Greenwich, Conn.) Conn.), 2012-12, Vol.14 (12), p.877-886 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 886 |
---|---|
container_issue | 12 |
container_start_page | 877 |
container_title | The journal of clinical hypertension (Greenwich, Conn.) |
container_volume | 14 |
creator | AlGhurair, Suliman A. Hughes, Christine A. Simpson, Scot H. Guirguis, Lisa M. |
description | J Clin Hypertens (Greenwich). 2012;14:877–886. ©2012 Wiley Periodicals, Inc.
Multiple barriers can influence adherence to antihypertensive medications. The aim of this systematic review was to determine what adherence barriers were included in each instrument and to describe the psychometric properties of the identified surveys. Barriers were characterized using the World Health Organization (WHO) Multidimensional Adherence Model with patient, condition, therapy, socioeconomic, and health care system/team‐related barriers. Five databases (Medline, Embase, Health and Psychological Instruments, CINHAL, and International Pharmaceutical s [IPA]) were searched from 1980 to September 2011. Our search identified 1712 citations; 74 articles met inclusion criteria and 51 unique surveys were identified. The Morisky Medication Adherence Scale was the most commonly used survey. Only 20 surveys (39%) have established reliability and validity evidence. According to the WHO Adherence Model domains, patient‐related barriers were most commonly addressed, while condition, therapy, and socioeconomic barriers were underrepresented. The complexity of adherence behavior requires robust self‐report measurements and the inclusion of barriers relevant to each unique patient population and intervention. |
doi_str_mv | 10.1111/j.1751-7176.2012.00699.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8108877</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1222232084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5069-9e5ccce7db5b15000d4622d3350397cb441f9869ec6399db99ec61ea5c031d743</originalsourceid><addsrcrecordid>eNqNUs2O0zAQjhCI_YFXQD5ySdaO4ziREFKpgIK2WrTLiqPl2JPWlRMXO-1uOfEIvAavxZPgbJdqOcFcPPZ836fxzJckiOCMxDhbZYQzknLCyyzHJM8wLus6u32UHB8Kj2PO8iIt48tRchLCCmNGaY2fJkc5zTHjjB0nPyfoahcG6ORgFLqErYEb5Fr0Kd6hH9AV2PbX9x-XsHZ-AI3eSO8N-DBiJnoJHnoFaHBo0g9muVtDRPXBbAHNQRsVVVwf0HUw_QINS0BfnLcazUDaYYku_EL25tsdCM03djDadCPd9dI-kJ87DfZZ8qSVNsDz-_M0uX739vN0lp5fvP8wnZynisUhpDUwpRRw3bCGMIyxLso815QyTGuumqIgbV2VNaiS1rVu6jEjIJnClGhe0NPk9V53vWk60CpOwUsr1t500u-Ek0b8XenNUizcVlQEVxXnUeDlvYB3XzcQBtGZoMBa2YPbBEFoyYsq5yX7NzSPEXdVjW1Ve6jyLgQP7aEjgsVoCrES4-7FuHsxmkLcmULcRuqLhz86EP-4IAJe7QE3xsLuv4XFx-ksJvQ3EJHKow</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1222232084</pqid></control><display><type>article</type><title>A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model</title><source>MEDLINE</source><source>Wiley Free Content</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><source>PubMed Central</source><creator>AlGhurair, Suliman A. ; Hughes, Christine A. ; Simpson, Scot H. ; Guirguis, Lisa M.</creator><creatorcontrib>AlGhurair, Suliman A. ; Hughes, Christine A. ; Simpson, Scot H. ; Guirguis, Lisa M.</creatorcontrib><description>J Clin Hypertens (Greenwich). 2012;14:877–886. ©2012 Wiley Periodicals, Inc.
Multiple barriers can influence adherence to antihypertensive medications. The aim of this systematic review was to determine what adherence barriers were included in each instrument and to describe the psychometric properties of the identified surveys. Barriers were characterized using the World Health Organization (WHO) Multidimensional Adherence Model with patient, condition, therapy, socioeconomic, and health care system/team‐related barriers. Five databases (Medline, Embase, Health and Psychological Instruments, CINHAL, and International Pharmaceutical s [IPA]) were searched from 1980 to September 2011. Our search identified 1712 citations; 74 articles met inclusion criteria and 51 unique surveys were identified. The Morisky Medication Adherence Scale was the most commonly used survey. Only 20 surveys (39%) have established reliability and validity evidence. According to the WHO Adherence Model domains, patient‐related barriers were most commonly addressed, while condition, therapy, and socioeconomic barriers were underrepresented. The complexity of adherence behavior requires robust self‐report measurements and the inclusion of barriers relevant to each unique patient population and intervention.</description><identifier>ISSN: 1524-6175</identifier><identifier>ISSN: 1751-7176</identifier><identifier>EISSN: 1751-7176</identifier><identifier>DOI: 10.1111/j.1751-7176.2012.00699.x</identifier><identifier>PMID: 23205755</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Antihypertensive Agents - adverse effects ; Antihypertensive Agents - economics ; Antihypertensive Agents - therapeutic use ; Consumer Health Information - methods ; Consumer Health Information - organization & administration ; Health Literacy ; Humans ; Hypertension - drug therapy ; Hypertension - psychology ; Medication Adherence - psychology ; Medication Adherence - statistics & numerical data ; Reproducibility of Results ; Review Paper ; Self Report ; Socioeconomic Factors ; World Health Organization</subject><ispartof>The journal of clinical hypertension (Greenwich, Conn.), 2012-12, Vol.14 (12), p.877-886</ispartof><rights>2012 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5069-9e5ccce7db5b15000d4622d3350397cb441f9869ec6399db99ec61ea5c031d743</citedby><cites>FETCH-LOGICAL-c5069-9e5ccce7db5b15000d4622d3350397cb441f9869ec6399db99ec61ea5c031d743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108877/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108877/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1416,1432,27923,27924,45573,45574,46408,46832,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23205755$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AlGhurair, Suliman A.</creatorcontrib><creatorcontrib>Hughes, Christine A.</creatorcontrib><creatorcontrib>Simpson, Scot H.</creatorcontrib><creatorcontrib>Guirguis, Lisa M.</creatorcontrib><title>A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model</title><title>The journal of clinical hypertension (Greenwich, Conn.)</title><addtitle>J Clin Hypertens (Greenwich)</addtitle><description>J Clin Hypertens (Greenwich). 2012;14:877–886. ©2012 Wiley Periodicals, Inc.
Multiple barriers can influence adherence to antihypertensive medications. The aim of this systematic review was to determine what adherence barriers were included in each instrument and to describe the psychometric properties of the identified surveys. Barriers were characterized using the World Health Organization (WHO) Multidimensional Adherence Model with patient, condition, therapy, socioeconomic, and health care system/team‐related barriers. Five databases (Medline, Embase, Health and Psychological Instruments, CINHAL, and International Pharmaceutical s [IPA]) were searched from 1980 to September 2011. Our search identified 1712 citations; 74 articles met inclusion criteria and 51 unique surveys were identified. The Morisky Medication Adherence Scale was the most commonly used survey. Only 20 surveys (39%) have established reliability and validity evidence. According to the WHO Adherence Model domains, patient‐related barriers were most commonly addressed, while condition, therapy, and socioeconomic barriers were underrepresented. The complexity of adherence behavior requires robust self‐report measurements and the inclusion of barriers relevant to each unique patient population and intervention.</description><subject>Antihypertensive Agents - adverse effects</subject><subject>Antihypertensive Agents - economics</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Consumer Health Information - methods</subject><subject>Consumer Health Information - organization & administration</subject><subject>Health Literacy</subject><subject>Humans</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - psychology</subject><subject>Medication Adherence - psychology</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Reproducibility of Results</subject><subject>Review Paper</subject><subject>Self Report</subject><subject>Socioeconomic Factors</subject><subject>World Health Organization</subject><issn>1524-6175</issn><issn>1751-7176</issn><issn>1751-7176</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUs2O0zAQjhCI_YFXQD5ySdaO4ziREFKpgIK2WrTLiqPl2JPWlRMXO-1uOfEIvAavxZPgbJdqOcFcPPZ836fxzJckiOCMxDhbZYQzknLCyyzHJM8wLus6u32UHB8Kj2PO8iIt48tRchLCCmNGaY2fJkc5zTHjjB0nPyfoahcG6ORgFLqErYEb5Fr0Kd6hH9AV2PbX9x-XsHZ-AI3eSO8N-DBiJnoJHnoFaHBo0g9muVtDRPXBbAHNQRsVVVwf0HUw_QINS0BfnLcazUDaYYku_EL25tsdCM03djDadCPd9dI-kJ87DfZZ8qSVNsDz-_M0uX739vN0lp5fvP8wnZynisUhpDUwpRRw3bCGMIyxLso815QyTGuumqIgbV2VNaiS1rVu6jEjIJnClGhe0NPk9V53vWk60CpOwUsr1t500u-Ek0b8XenNUizcVlQEVxXnUeDlvYB3XzcQBtGZoMBa2YPbBEFoyYsq5yX7NzSPEXdVjW1Ve6jyLgQP7aEjgsVoCrES4-7FuHsxmkLcmULcRuqLhz86EP-4IAJe7QE3xsLuv4XFx-ksJvQ3EJHKow</recordid><startdate>201212</startdate><enddate>201212</enddate><creator>AlGhurair, Suliman A.</creator><creator>Hughes, Christine A.</creator><creator>Simpson, Scot H.</creator><creator>Guirguis, Lisa M.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>5PM</scope></search><sort><creationdate>201212</creationdate><title>A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model</title><author>AlGhurair, Suliman A. ; Hughes, Christine A. ; Simpson, Scot H. ; Guirguis, Lisa M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5069-9e5ccce7db5b15000d4622d3350397cb441f9869ec6399db99ec61ea5c031d743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antihypertensive Agents - adverse effects</topic><topic>Antihypertensive Agents - economics</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Consumer Health Information - methods</topic><topic>Consumer Health Information - organization & administration</topic><topic>Health Literacy</topic><topic>Humans</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - psychology</topic><topic>Medication Adherence - psychology</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Reproducibility of Results</topic><topic>Review Paper</topic><topic>Self Report</topic><topic>Socioeconomic Factors</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AlGhurair, Suliman A.</creatorcontrib><creatorcontrib>Hughes, Christine A.</creatorcontrib><creatorcontrib>Simpson, Scot H.</creatorcontrib><creatorcontrib>Guirguis, Lisa M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AlGhurair, Suliman A.</au><au>Hughes, Christine A.</au><au>Simpson, Scot H.</au><au>Guirguis, Lisa M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model</atitle><jtitle>The journal of clinical hypertension (Greenwich, Conn.)</jtitle><addtitle>J Clin Hypertens (Greenwich)</addtitle><date>2012-12</date><risdate>2012</risdate><volume>14</volume><issue>12</issue><spage>877</spage><epage>886</epage><pages>877-886</pages><issn>1524-6175</issn><issn>1751-7176</issn><eissn>1751-7176</eissn><abstract>J Clin Hypertens (Greenwich). 2012;14:877–886. ©2012 Wiley Periodicals, Inc.
Multiple barriers can influence adherence to antihypertensive medications. The aim of this systematic review was to determine what adherence barriers were included in each instrument and to describe the psychometric properties of the identified surveys. Barriers were characterized using the World Health Organization (WHO) Multidimensional Adherence Model with patient, condition, therapy, socioeconomic, and health care system/team‐related barriers. Five databases (Medline, Embase, Health and Psychological Instruments, CINHAL, and International Pharmaceutical s [IPA]) were searched from 1980 to September 2011. Our search identified 1712 citations; 74 articles met inclusion criteria and 51 unique surveys were identified. The Morisky Medication Adherence Scale was the most commonly used survey. Only 20 surveys (39%) have established reliability and validity evidence. According to the WHO Adherence Model domains, patient‐related barriers were most commonly addressed, while condition, therapy, and socioeconomic barriers were underrepresented. The complexity of adherence behavior requires robust self‐report measurements and the inclusion of barriers relevant to each unique patient population and intervention.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>23205755</pmid><doi>10.1111/j.1751-7176.2012.00699.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1524-6175 |
ispartof | The journal of clinical hypertension (Greenwich, Conn.), 2012-12, Vol.14 (12), p.877-886 |
issn | 1524-6175 1751-7176 1751-7176 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8108877 |
source | MEDLINE; Wiley Free Content; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals; PubMed Central |
subjects | Antihypertensive Agents - adverse effects Antihypertensive Agents - economics Antihypertensive Agents - therapeutic use Consumer Health Information - methods Consumer Health Information - organization & administration Health Literacy Humans Hypertension - drug therapy Hypertension - psychology Medication Adherence - psychology Medication Adherence - statistics & numerical data Reproducibility of Results Review Paper Self Report Socioeconomic Factors World Health Organization |
title | A Systematic Review of Patient Self‐Reported Barriers of Adherence to Antihypertensive Medications Using the World Health Organization Multidimensional Adherence Model |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-10T12%3A38%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Systematic%20Review%20of%20Patient%20Self%E2%80%90Reported%20Barriers%20of%20Adherence%20to%20Antihypertensive%20Medications%20Using%20the%20World%20Health%20Organization%20Multidimensional%20Adherence%20Model&rft.jtitle=The%20journal%20of%20clinical%20hypertension%20(Greenwich,%20Conn.)&rft.au=AlGhurair,%20Suliman%20A.&rft.date=2012-12&rft.volume=14&rft.issue=12&rft.spage=877&rft.epage=886&rft.pages=877-886&rft.issn=1524-6175&rft.eissn=1751-7176&rft_id=info:doi/10.1111/j.1751-7176.2012.00699.x&rft_dat=%3Cproquest_pubme%3E1222232084%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1222232084&rft_id=info:pmid/23205755&rfr_iscdi=true |